|2.||Myositis (Idiopathic Inflammatory Myopathies)
|1.||Salomon, Benoit: 2 articles (01/2013 - 03/2009)|
|2.||Allenbach, Yves: 2 articles (01/2013 - 03/2009)|
|3.||Benveniste, Olivier: 2 articles (01/2013 - 03/2009)|
|4.||Klatzmann, David: 2 articles (01/2013 - 03/2009)|
|5.||Miyasaka, Nobuyuki: 2 articles (10/2009 - 11/2005)|
|6.||Nanki, Toshihiro: 2 articles (10/2009 - 11/2005)|
|7.||Suzuki, Fumihito: 2 articles (10/2009 - 11/2005)|
|8.||Matsumoto, Yoh: 2 articles (10/2007 - 09/2007)|
|9.||Kohyama, Kuniko: 2 articles (10/2007 - 09/2007)|
|10.||Zeng, Ling: 1 article (01/2014)|
|2.||Am 80 (tamibarotene)IBA
10/01/2009 - "The present study was undertaken to examine the effects of a synthetic retinoid, Am80, on experimental autoimmune myositis as well as on Th phenotype development and antibody production. "
10/01/2009 - "The synthetic retinoid Am80 has an inhibitory effect on experimental autoimmune myositis. "
10/01/2009 - "In mice with experimental autoimmune myositis, orally administered Am80 significantly reduced the number of infiltrating inflammatory cells and the expression of tumor necrosis factor alpha and interleukin-1beta (IL-1beta) in muscle. "
10/01/2009 - "Moreover, Am80 increased production of interferon-gamma, IL-4, and IL-10, but not IL-17, by myosin-stimulated splenic T cells of mice with experimental autoimmune myositis, suggesting that it could enhance differentiation into Th1 and Th2, but not Th17, in vivo. "
10/01/2009 - "Experimental autoimmune myositis was induced in SJL/J mice by immunization with rabbit myosin. "
11/15/2005 - "We induced experimental autoimmune myositis (EAM) in SJL/J mice by immunization with rabbit myosin and CFA. "
06/01/2003 - "Skeletal muscle myosin is the autoantigen for experimental autoimmune myositis."
10/22/1997 - "Experimental autoimmune myositis (EAM) was induced in Lewis rats by immunization with partially purified and purified skeletal myosin. "
08/03/1999 - "To obtain a good animal model for polymyositis, we previously induced experimental autoimmune myositis (EAM) in Lewis rats by immunization with partially purified skeletal myosin. "
|4.||Nonmuscle Myosin Type IIBIBA
05/01/2001 - "An experimental autoimmune myositis (EAM) model was produced in SJL/J mice by an immunization with rabbit myosin B (MB) fraction. "
12/01/1996 - "An experimental autoimmune myositis (EAM) was produced by immunizing SJL/J mice with the myosin B (MB) fraction of the syngeneic muscle. "
12/01/1996 - "Experimental autoimmune myositis in SJL/J mice produced by immunization with syngeneic myosin B fraction. "
04/01/1987 - "Experimental autoimmune myositis (EAM), was produced in SJL/J mice by injection of an emulsion of crude syngeneic muscle homogenate and complete Freund's adjuvant (CFA). "
03/01/2009 - "To develop a reproducible experimental autoimmune myositis model of polymyositis, mice were immunized once a week for 3 weeks with 1 mg of partially purified myosin emulsified in complete Freund's adjuvant. "
06/15/1989 - "Aberrant expression of class II MHC antigens by skeletal muscle endothelial cells in experimental autoimmune myositis."
01/01/1998 - "In addition, we identified the antigen and characterized immunopathologically an autoimmune inflammatory disease of skeletal muscle, experimental autoimmune myositis (EAM), a model for the human inflammatory muscle disease polymyositis."
|8.||Interleukin-1beta (Interleukin 1 beta)IBA
|9.||Interleukin-17 (Interleukin 27)IBA
|10.||Sirolimus (Rapamycin)FDA Link